Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 1, 2017
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
[ Wed, Nov 01st 2017
] - WOPRAI
Tue, October 31, 2017
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Oct 31st 2017
] - WOPRAI
Edward Tenthoff Initiated (SYRS) at Buy and Held Target at $300 on, Oct 31st, 2017
Edward Tenthoff of Piper Sandler, Initiated "Syros Pharmaceuticals, Inc." (SYRS) at Buy and Held Target at $300 on, Oct 31st, 2017.
Edward has made no other calls on SYRS in the last 4 months.
There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Michael King of "JMP Securities" Upgraded from Hold to Buy on, Thursday, September 28th, 2017
Similar Stocks and Investing Articles
[ Mon, Oct 09th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Fri, Jul 14th 2017
] - WOPRAI
[ Tue, Apr 25th 2017
] - WOPRAI
[ Tue, Mar 21st 2017
] - WOPRAI
[ Wed, Jan 04th 2017
] - WOPRAI
[ Wed, Oct 28th 2015
] - WOPRAI
[ Mon, Jun 15th 2015
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Wed, May 23rd 2012
] - WOPRAI